Cinacalcet Tablets Recalled Due to Nitrosamine Impurity Exceeding Limits
AvKARE is recalling 2,796 bottles of Cinacalcet Tablets (90 mg) nationwide due to manufacturing deviations resulting in N-Nitroso-Cinacalcet above acceptable intake limits.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard—a nitrosamine impurity above acceptable limits—represents a risk-of-harm product where contamination has been identified but no adverse health effects have been reported. Per the rubric, this scenario scores as High (3).
Plain-English summary
AvKARE is recalling 2,796 bottles of Cinacalcet Tablets, 90 mg, 30-count bottles (Lot #44405, Exp 12/31/2024, NDC 42291-461-30) distributed nationwide due to manufacturing deviations.
Testing identified the presence of N-Nitroso-Cinacalcet, a nitrosamine drug substance-related impurity, at levels exceeding the acceptable daily intake limit for this substance. This was discovered during current good manufacturing practice (CGMP) quality control.
Patients currently taking affected medication should consult their healthcare provider or pharmacist. Do not stop taking the medication without medical guidance. Return affected bottles to a pharmacy for proper disposal.
The recalled product
- Product
- Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-461-30
- Manufacturer
- AvKARE
- Category
- Drug — Prescription Medication
- Affected units
- 2,796
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 44405
- Exp 12/31/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by AvKARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · AvKARE
See all →- HighAmantadine hydrochloride capsules recalled after failing dissolution specifications
FDA (Drugs) · 2026-03-04
- ModerateRosuvastatin tablets recalled after failing a dissolution specification
FDA (Drugs) · 2026-01-14
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighAvKare chlorpromazine 100 mg cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
- HighAvKare chlorpromazine unit dose cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
Same hazard · nitrosamine impurity
See all →- HighEnovachem duloxetine capsules exceed the nitrosamine acceptable intake limit
FDA (Drugs) · 2026-06-10
- HighCipla cinacalcet 60 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
- HighCipla cinacalcet 30 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
- HighCipla cinacalcet 90 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08